Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1303551

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1303551

Global Nanobiotechnology Market Size study & Forecast, by Product, by Application, by Technology, by End-use and Regional Analysis, 2023-2030

PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Nanobiotechnology Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Nanobiotechnology is a multidisciplinary field that combines nanotechnology and biology to develop novel tools, techniques, and materials for biological and medical applications. It involves the use of nanoscale materials, such as nanoparticles, nanotubes, and nanofibers, for various biological and medical purposes, including drug delivery, imaging, diagnostics, and biosensing. Nanobiotechnology is aimed at developing innovative solutions to address various challenges in healthcare, agriculture, environment, and other industries by harnessing the unique properties of nanoscale materials. The major driving factors for the Global Nanobiotechnology Market are increasing demand for advanced diagnostics and therapeutics and rising investments in R&D. Moreover, growing applications in drug delivery and increasing focus on personalized medicine are creating lucrative growth opportunities for the market over the forecast period 2023-2030.

Governments and private organizations are investing heavily in nanobiotechnology R&D, leading to the development of new technologies and products. These investments are driving the growth of the nanobiotechnology market by creating new opportunities for the development of innovative products and solutions. For instance, in November 2020, researchers at the University of Cambridge developed a new type of sensor using nanotechnology that can detect the presence of COVID-19 in wastewater before the virus spreads to the population. Along with this, in March 2021, scientists at the University of Manchester developed a new nanotechnology-based treatment for cancer that uses tiny particles called "quantum dots" to destroy cancer cells. Furthermore, in May 2021, researchers at the University of California developed a new type of nanotechnology-based vaccine that can be used against multiple strains of the flu virus. However, the high cost of Nanobiotechnology stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Nanobiotechnology Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the nanobiotechnology market in 2020, owing to the presence of established market players, well-developed healthcare infrastructure, and increasing government funding for nanobiotechnology research. The United States is the largest contributor to the nanobiotechnology market in this region. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, due to the rising investments in R&D activities, increasing healthcare expenditure, and the growing demand for advanced diagnostic and therapeutic technologies. China, Japan, and India are the major contributors to the nanobiotechnology market in this region.

Major market players included in this report are:

  • Thermo Fisher Scientific Inc.
  • Abcam plc
  • GenScript Biotech Corporation
  • NanoTemper Technologies GmbH
  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Nanosens Innovations
  • AstraZeneca plc

Recent Developments in the Market:

  • In 2021, Thermo Fisher Scientific launched the Applied Biosystems Axiom Microbiome Array, a genotyping tool for the detection and analysis of microbiomes. This array uses nanobiotechnology to identify and analyze microbial communities in human, animal, and environmental samples.

Global Nanobiotechnology Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Application, Technology, End-use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Nanobiotechnology instruments
  • Nanobiotechnology services
  • Nanobiotechnology products

By Application:

  • Drug Delivery
  • Genomics
  • Proteomics
  • Diagnostics
  • Others

By Technology:

  • Nanoparticles
  • Nanotubes
  • Nanoshells
  • Others

By End-use:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Nanobiotechnology Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Nanobiotechnology Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Nanobiotechnology Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Nanobiotechnology Market, by Technology, 2020-2030 (USD Billion)
    • 1.2.5. Nanobiotechnology Market, by End-use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Nanobiotechnology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Nanobiotechnology Market Dynamics

  • 3.1. Nanobiotechnology Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing demand for advanced diagnostics and therapeutics
      • 3.1.1.2. Rising investments in R&D
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Nanobiotechnology
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing applications in drug delivery
      • 3.1.3.2. Increasing focus on personalized medicine

Chapter 4. Global Nanobiotechnology Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Nanobiotechnology Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Nanobiotechnology Market by Product, Performance - Potential Analysis
  • 5.3. Global Nanobiotechnology Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Nanobiotechnology Market, Sub Segment Analysis
    • 5.4.1. Nanobiotechnology instruments
    • 5.4.2. Nanobiotechnology services
    • 5.4.3. Nanobiotechnology products

Chapter 6. Global Nanobiotechnology Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Nanobiotechnology Market by Application, Performance - Potential Analysis
  • 6.3. Global Nanobiotechnology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Nanobiotechnology Market, Sub Segment Analysis
    • 6.4.1. Drug Delivery
    • 6.4.2. Genomics
    • 6.4.3. Proteomics
    • 6.4.4. Diagnostics
    • 6.4.5. Others

Chapter 7. Global Nanobiotechnology Market, by Technology

  • 7.1. Market Snapshot
  • 7.2. Global Nanobiotechnology Market by Technology, Performance - Potential Analysis
  • 7.3. Global Nanobiotechnology Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
  • 7.4. Nanobiotechnology Market, Sub Segment Analysis
    • 7.4.1. Nanoparticles
    • 7.4.2. Nanotubes
    • 7.4.3. Nanoshells
    • 7.4.4. Others

Chapter 8. Global Nanobiotechnology Market, by End-use

  • 8.1. Market Snapshot
  • 8.2. Global Nanobiotechnology Market by End-use, Performance - Potential Analysis
  • 8.3. Global Nanobiotechnology Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
  • 8.4. Nanobiotechnology Market, Sub Segment Analysis
    • 8.4.1. Pharmaceutical and Biotechnology Companies
    • 8.4.2. Academic and Research Institutes
    • 8.4.3. Diagnostic Laboratories
    • 8.4.4. Others

Chapter 9. Global Nanobiotechnology Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Nanobiotechnology Market, Regional Market Snapshot
  • 9.4. North America Nanobiotechnology Market
    • 9.4.1. U.S. Nanobiotechnology Market
      • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Nanobiotechnology Market
  • 9.5. Europe Nanobiotechnology Market Snapshot
    • 9.5.1. U.K. Nanobiotechnology Market
    • 9.5.2. Germany Nanobiotechnology Market
    • 9.5.3. France Nanobiotechnology Market
    • 9.5.4. Spain Nanobiotechnology Market
    • 9.5.5. Italy Nanobiotechnology Market
    • 9.5.6. Rest of Europe Nanobiotechnology Market
  • 9.6. Asia-Pacific Nanobiotechnology Market Snapshot
    • 9.6.1. China Nanobiotechnology Market
    • 9.6.2. India Nanobiotechnology Market
    • 9.6.3. Japan Nanobiotechnology Market
    • 9.6.4. Australia Nanobiotechnology Market
    • 9.6.5. South Korea Nanobiotechnology Market
    • 9.6.6. Rest of Asia Pacific Nanobiotechnology Market
  • 9.7. Latin America Nanobiotechnology Market Snapshot
    • 9.7.1. Brazil Nanobiotechnology Market
    • 9.7.2. Mexico Nanobiotechnology Market
  • 9.8. Middle East & Africa Nanobiotechnology Market
    • 9.8.1. Saudi Arabia Nanobiotechnology Market
    • 9.8.2. South Africa Nanobiotechnology Market
    • 9.8.3. Rest of Middle East & Africa Nanobiotechnology Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Thermo Fisher Scientific Inc.
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Abcam plc
    • 10.3.3. GenScript Biotech Corporation
    • 10.3.4. NanoTemper Technologies GmbH
    • 10.3.5. Agilent Technologies, Inc.
    • 10.3.6. Bruker Corporation
    • 10.3.7. Bio-Rad Laboratories, Inc.
    • 10.3.8. PerkinElmer, Inc.
    • 10.3.9. Nanosens Innovations
    • 10.3.10. AstraZeneca plc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Nanobiotechnology Market, report scope
  • TABLE 2. Global Nanobiotechnology Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Nanobiotechnology Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Nanobiotechnology Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Nanobiotechnology Market estimates & forecasts by Technology 2020-2030 (USD Billion)
  • TABLE 6. Global Nanobiotechnology Market estimates & forecasts by End-use 2020-2030 (USD Billion)
  • TABLE 7. Global Nanobiotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Nanobiotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Nanobiotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Nanobiotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Nanobiotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Nanobiotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Nanobiotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Nanobiotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Nanobiotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Nanobiotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. U.S. Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21. Canada Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. Canada Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24. UK Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. UK Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27. Germany Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. Germany Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30. France Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. France Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33. Italy Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Italy Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36. Spain Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. Spain Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39. RoE Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. RoE Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42. China Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. China Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45. India Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. India Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48. Japan Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. Japan Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51. South Korea Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. South Korea Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54. Australia Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. Australia Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60. Brazil Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Brazil Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63. Mexico Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. Mexico Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66. RoLA Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. RoLA Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. Saudi Arabia Nanobiotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 69. South Africa Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. RoMEA Nanobiotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Nanobiotechnology Market
  • TABLE 72. List of primary sources, used in the study of global Nanobiotechnology Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Nanobiotechnology Market, research methodology
  • FIG 2. Global Nanobiotechnology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Nanobiotechnology Market, key trends 2022
  • FIG 5. Global Nanobiotechnology Market, growth prospects 2023-2030
  • FIG 6. Global Nanobiotechnology Market, porters 5 force model
  • FIG 7. Global Nanobiotechnology Market, pest analysis
  • FIG 8. Global Nanobiotechnology Market, value chain analysis
  • FIG 9. Global Nanobiotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Nanobiotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Nanobiotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Nanobiotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Nanobiotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Nanobiotechnology Market, regional snapshot 2020 & 2030
  • FIG 15. North America Nanobiotechnology Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Nanobiotechnology Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia Pacific Nanobiotechnology Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Nanobiotechnology Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Nanobiotechnology Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!